Skip to main content

Table 3 Primers designed for amplification and sequencing of HBV reverse transcriptase domain

From: Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

Primer ID

Nucleotide sequences

 

Product size (bp)

 

Nucleotide positions

HBV TAQ 1

5' GTG TCT GCG GCG TTT TATCA -3'

Sense

97

DNA quantification

379-398

HBV TAQ 2

5' GAC AAA CGG GCA ACA TAC CTT-3'

Antisense

  

476-456

MM HBRT5

5' - ATCCTGCTGCTATGCCT - 3'

Sense

576

polymerase Amplification

410 - 426

MM HBRT6

5' - ACTTTCCAATCAATAGGCC - 3'

Antisense

  

986 - 968